Breaking News Instant updates and real-time market news.

ESRX

Express Scripts

$70.34

0.43 (0.62%)

16:55
10/05/16
10/05
16:55
10/05/16
16:55

Express Scripts initiated with a Neutral at UBS

Target $76.

  • 26

    Oct

  • 06

    Nov

ESRX Express Scripts
$70.34

0.43 (0.62%)

08/02/16
BMOC
08/02/16
NO CHANGE
BMOC
Outperform
Horizon Pharma scored 'important win' with CVS, says BMO Capital
BMO Capital analyst Gary Nachman said Horizon Pharma (HZNP) securing covered status for Duexis and Vimovo with CVS/Caremark (CVS) is an "important win" for the drugmaker that demonstrates it is improving its execution on the managed care front. While Express Scripts (ESRX) still has Duexis and Vimovo on its exclusion list for 2017, Horizon indicated that it is still in discussions that have been "constructive," noted Nachman, who keeps an Outperform rating on Horizon shares.
08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$373.91

-1.19 (-0.32%)

11:48
09/21/17
09/21
11:48
09/21/17
11:48
Periodicals
Tesla to stop selling cheapest Model S this weekend, Business Insider says »

Tesla will stop offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FANG

Diamondback Energy

$97.32

3.04 (3.22%)

11:45
09/21/17
09/21
11:45
09/21/17
11:45
Hot Stocks
Diamondback Energy EVP Molnar sells 5,000 shares »

Diamondback Energy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FINL

Finish Line

$9.43

-0.13 (-1.36%)

11:40
09/21/17
09/21
11:40
09/21/17
11:40
Options
Large spread in Finish Line ahead of earnings »

Large spread in Finish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

11:40
09/21/17
09/21
11:40
09/21/17
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SQ

Square

$28.24

-0.23 (-0.81%)

, INTC

Intel

$37.07

-0.16 (-0.43%)

11:32
09/21/17
09/21
11:32
09/21/17
11:32
Hot Stocks
Square names Intel's Naveen Rao to board »

Square (SQ) announced…

SQ

Square

$28.24

-0.23 (-0.81%)

INTC

Intel

$37.07

-0.16 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 05

    Oct

  • 22

    Oct

WASH

Washington Trust

$53.05

0.15 (0.28%)

11:31
09/21/17
09/21
11:31
09/21/17
11:31
Hot Stocks
Washington Trust increases quarterly dividend by 1c »

The board of Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

, CRZBY

Commerzbank

$13.02

0.28 (2.20%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Periodicals
UniCredit expresses interest in Commerzbank merger, Reuters reports »

UniCredit recently…

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$24.86

-0.33 (-1.31%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Options
Short-term call buyers drilling for profits in Market Vectors Oil Services Fund »

Short-term call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$98.12

1.92 (2.00%)

11:29
09/21/17
09/21
11:29
09/21/17
11:29
Hot Stocks
Intercept sinks after FDA safety communication cites 19 patient deaths »

The FDA, in its safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOR

ShoreTel

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Hot Stocks
Breaking Hot Stocks news story on ShoreTel »

Gardner Lewis reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$97.46

1.46 (1.52%)

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Periodicals
Equifax CEO to testify to Senate panel on October 4, Bloomberg says »

The Senate Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FSLR

First Solar

$48.85

-0.01 (-0.02%)

, SPWR

SunPower

$7.86

-0.51 (-6.09%)

11:24
09/21/17
09/21
11:24
09/21/17
11:24
Hot Stocks
Before the Move: Watch First Solar, others ahead of ITC decision »

With an ITC Section 201…

FSLR

First Solar

$48.85

-0.01 (-0.02%)

SPWR

SunPower

$7.86

-0.51 (-6.09%)

CSIQ

Canadian Solar

$16.02

-0.69 (-4.13%)

JKS

JinkoSolar

$26.13

-0.16 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNG

Golar LNG

$21.15

0.66 (3.22%)

11:20
09/21/17
09/21
11:20
09/21/17
11:20
Options
Golar LNG calls active as shares see relative strength »

Golar LNG calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
09/21/17
09/21
11:17
09/21/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
09/21/17
09/21
11:16
09/21/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.16

-0.64 (-0.78%)

11:15
09/21/17
09/21
11:15
09/21/17
11:15
Options
Capital One put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

11:15
09/21/17
09/21
11:15
09/21/17
11:15
General news
Treasury announced an $88 B 3-pronged package of coupon auctions »

Treasury announced an $88…

PEG

PSEG

$46.31

1.08 (2.39%)

11:10
09/21/17
09/21
11:10
09/21/17
11:10
Conference/Events
PSEG management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 05

    Nov

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
5-Yr Note Announcement Offering Amount data reported »

5-Yr Note Announcement…

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
2-Yr Note Announcement CUSIP Number data reported »

2-Yr Note Announcement…

11:08
09/21/17
09/21
11:08
09/21/17
11:08
General news
2-Yr Note Announcement Offering Amount data reported »

2-Yr Note Announcement…

11:05
09/21/17
09/21
11:05
09/21/17
11:05
General news
2-Yr FRN Note Announcement CUSIP Number data reported »

2-Yr FRN Note…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.